Market Cap 75.77M
Revenue (ttm) 200,000.00
Net Income (ttm) -26.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13,085.00%
Debt to Equity Ratio -0.25
Volume 66,200
Avg Vol 595,970
Day's Range N/A - N/A
Shares Out 12.78M
Stochastic %K 85%
Beta 0.91
Analysts Strong Sell
Price Target $32.00

Company Profile

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic...

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 801 676 9695
Website: clene.com
Address:
6550 South Millrock Drive, Suite G50, Salt Lake City, United States
Mulhollandr
Mulhollandr Jun. 18 at 9:23 PM
$CLNN I know we all saw it but just feel compelled to point out the 35K purchase at close. Have a nice long weekend all.
0 · Reply
Mulhollandr
Mulhollandr Jun. 18 at 3:50 PM
$CLNN less than 2 weeks till Q3 starts. 7 trading days, then the NDA filing can happen at any moment.
1 · Reply
Mulhollandr
Mulhollandr Jun. 17 at 5:40 PM
$CLNN 😃🍀🍀
2 · Reply
paule815
paule815 Jun. 17 at 10:37 AM
$CLNN 4.10?!?!?!?!? That’s just disrespectful.
2 · Reply
Mulhollandr
Mulhollandr Jun. 16 at 9:05 PM
$CLNN so I’m just now seeing the 100k in volume in the last 2 minutes of trading. WTF was that?
2 · Reply
Takeover24
Takeover24 Jun. 16 at 8:50 PM
$CLNN I added a few thousand shares at $5.52 today. First add in a while but don't expect any major movement until the fall when the NDA is accepted (may see a small bump on filing as well). But if you continue to believe in the story (which I do), this quiet period may be the last time to add significant shares at this level. Good luck to all of us.
1 · Reply
paule815
paule815 Jun. 16 at 5:35 PM
$CLNN so what’s the excuse or reasoning for the performance today?
1 · Reply
paule815
paule815 Jun. 16 at 3:41 PM
$CLNN red today
1 · Reply
Mulhollandr
Mulhollandr Jun. 15 at 11:49 PM
$CLNN Brian’s strength to fight for ALS patients is inspiring.
1 · Reply
vijaykamat14
vijaykamat14 Jun. 15 at 8:59 PM
$CLNN manifesting $20
1 · Reply
Latest News on CLNN
Clene reports Q1 EPS (69c), consensus (70c)

2026-05-14T16:30:10.000Z - 5 weeks ago

Clene reports Q1 EPS (69c), consensus (70c)


Clene Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 5 weeks ago

Clene Quarterly report: Q1 2026


Clene Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 5 weeks ago

Clene Earnings release: Q1 2026


Clene price target raised to $50 from $48 at Canaccord

2026-05-08T11:23:32.000Z - 6 weeks ago

Clene price target raised to $50 from $48 at Canaccord


Clene Transcript: Emerging Growth Conference 92

May 6, 2026, 3:25 PM EDT - 6 weeks ago

Clene Transcript: Emerging Growth Conference 92


Clene to Present at Upcoming May Conferences

May 5, 2026, 8:00 AM EDT - 6 weeks ago

Clene to Present at Upcoming May Conferences


Clene Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 2 months ago

Clene Proxy statement: Proxy filing


Clene Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 2 months ago

Clene Proxy statement: Proxy filing


Clene reports FY25 EPS ($2.65), consensus ($2.35)

2026-03-12T12:12:18.000Z - 3 months ago

Clene reports FY25 EPS ($2.65), consensus ($2.35)


Clene Annual report: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 3 months ago

Clene Annual report: Q4 2025


Clene Annual report: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 3 months ago

Clene Annual report: Q4 2025


Clene Earnings release: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 3 months ago

Clene Earnings release: Q4 2025


Clene Transcript: Emerging Growth Virtual Conference

Feb 25, 2026, 1:45 PM EST - 4 months ago

Clene Transcript: Emerging Growth Virtual Conference


Clene issues letter to shareholders on CNM-Au8 2026 catalysts

2026-02-24T13:13:07.000Z - 4 months ago

Clene issues letter to shareholders on CNM-Au8 2026 catalysts


Clene to Present at the Emerging Growth Conference

Feb 19, 2026, 8:30 AM EST - 4 months ago

Clene to Present at the Emerging Growth Conference


Clene Transcript: Emerging Growth Conference 89

Jan 21, 2026, 3:10 PM EST - 5 months ago

Clene Transcript: Emerging Growth Conference 89


Clene announces over $28M registered direct offering

2026-01-09T13:41:01.000Z - 5 months ago

Clene announces over $28M registered direct offering


Clene Announces Registered Direct Offering of Over $28 Million

Jan 9, 2026, 8:30 AM EST - 5 months ago

Clene Announces Registered Direct Offering of Over $28 Million


Clene Transcript: Emerging Growth Conference 88

Dec 10, 2025, 4:25 PM EST - 6 months ago

Clene Transcript: Emerging Growth Conference 88


Clene price target raised to $30 from $20 at Maxim

2025-12-03T18:15:36.000Z - 7 months ago

Clene price target raised to $30 from $20 at Maxim


Clene Transcript: Study Update

Dec 3, 2025, 8:30 AM EST - 7 months ago

Clene Transcript: Study Update


Clene Press release: Study Update

Dec 3, 2025, 8:30 AM EST - 7 months ago

Clene Press release: Study Update


Clene Slides: Study Update

Dec 3, 2025, 8:30 AM EST - 7 months ago

Clene Slides: Study Update


Clene to Provide CNM-Au8® ALS Program Update

Dec 2, 2025, 5:39 PM EST - 7 months ago

Clene to Provide CNM-Au8® ALS Program Update


Clene reports Q3 EPS (85c), consensus (56c)

2025-11-13T13:10:28.000Z - 7 months ago

Clene reports Q3 EPS (85c), consensus (56c)


Clene sees cash runway into 2Q26

2025-11-13T13:10:16.000Z - 7 months ago

Clene sees cash runway into 2Q26


Clene Earnings release: Q3 2025

Nov 13, 2025, 8:00 AM EST - 7 months ago

Clene Earnings release: Q3 2025


Clene Quarterly report: Q3 2025

Nov 13, 2025, 8:00 AM EST - 7 months ago

Clene Quarterly report: Q3 2025


Clene Transcript: Emerging Growth Conference

Oct 23, 2025, 3:10 PM EDT - 8 months ago

Clene Transcript: Emerging Growth Conference


Clene announces presentation of combined REPAIR-MS results

2025-09-25T12:10:32.000Z - 9 months ago

Clene announces presentation of combined REPAIR-MS results


Clene price target lowered to $31 from $33 at Benchmark

2025-09-10T12:00:43.000Z - 10 months ago

Clene price target lowered to $31 from $33 at Benchmark


Clene files to sell 491,496 shares of common stock for holders

2025-09-05T20:20:08.000Z - 10 months ago

Clene files to sell 491,496 shares of common stock for holders


Clene Registration statement: Registration Filing

Sep 5, 2025, 8:00 AM EDT - 10 months ago

Clene Registration statement: Registration Filing


Clene Transcript: Emerging Growth Conference 85

Aug 20, 2025, 2:20 PM EDT - 10 months ago

Clene Transcript: Emerging Growth Conference 85


Clene price target lowered to $48 from $83 at Canaccord

2025-08-18T10:40:11.000Z - 10 months ago

Clene price target lowered to $48 from $83 at Canaccord


Clene reports Q2 EPS (78c) vs ($1.06) last year

2025-08-14T12:45:43.000Z - 11 months ago

Clene reports Q2 EPS (78c) vs ($1.06) last year


Clene Earnings release: Q2 2025

Aug 14, 2025, 8:30 AM EDT - 11 months ago

Clene Earnings release: Q2 2025


Clene Quarterly report: Q2 2025

Aug 14, 2025, 8:30 AM EDT - 11 months ago

Clene Quarterly report: Q2 2025


Clene to Present at the Canaccord 45th Annual Growth Conference

Aug 5, 2025, 8:30 AM EDT - 11 months ago

Clene to Present at the Canaccord 45th Annual Growth Conference


Clene Transcript: Emerging Growth Conference 84

Jul 17, 2025, 3:10 PM EDT - 1 year ago

Clene Transcript: Emerging Growth Conference 84


Clene Transcript: Q2 Virtual Investor Summit Event

Jun 10, 2025, 1:00 PM EDT - 1 year ago

Clene Transcript: Q2 Virtual Investor Summit Event


Clene Transcript: Emerging Growth Conference 82

May 21, 2025, 3:10 PM EDT - 1 year ago

Clene Transcript: Emerging Growth Conference 82


Clene Slides: Investor Presentation

May 14, 2025, 7:00 AM EDT - 1 year ago

Clene Slides: Investor Presentation


Clene Earnings release: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

Clene Earnings release: Q1 2025


Clene Quarterly report: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

Clene Quarterly report: Q1 2025


Clene Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Clene Proxy statement: Proxy Filing


Clene Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Clene Proxy statement: Proxy Filing


Clene Proxy statement: Proxy Filing

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Clene Proxy statement: Proxy Filing


Clene Annual report: Q4 2024

Mar 24, 2025, 9:00 AM EDT - 1 year ago

Clene Annual report: Q4 2024


Clene Earnings release: Q4 2024

Mar 24, 2025, 9:00 AM EDT - 1 year ago

Clene Earnings release: Q4 2024


Clene Registration statement: Registration Filing

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Clene Registration statement: Registration Filing


Clene Transcript: 37th Annual ROTH Conference

Mar 18, 2025, 12:30 PM EDT - 1 year ago

Clene Transcript: 37th Annual ROTH Conference


Clene to Present at the 37TH Annual Roth Conference

Mar 6, 2025, 8:30 AM EST - 1 year ago

Clene to Present at the 37TH Annual Roth Conference


Clene Registration statement: Registration Filing

Jan 24, 2025, 7:00 AM EST - 1 year ago

Clene Registration statement: Registration Filing


Clene Slides: Investor Presentation

Dec 10, 2024, 7:00 AM EST - 1 year ago

Clene Slides: Investor Presentation


Clene Quarterly report: Q3 2024

Nov 13, 2024, 7:00 AM EST - 1 year ago

Clene Quarterly report: Q3 2024


Clene Earnings release: Q3 2024

Nov 13, 2024, 7:00 AM EST - 1 year ago

Clene Earnings release: Q3 2024


Clene Registration statement: Registration Filing

Nov 13, 2024, 7:00 AM EST - 1 year ago

Clene Registration statement: Registration Filing


Clene Quarterly report: Q2 2024

Aug 7, 2024, 7:00 AM EDT - 2 years ago

Clene Quarterly report: Q2 2024


Clene Earnings release: Q2 2024

Aug 7, 2024, 7:00 AM EDT - 2 years ago

Clene Earnings release: Q2 2024


Clene Announces 1-for-20 Reverse Stock Split

Jul 9, 2024, 8:00 AM EDT - 2 years ago

Clene Announces 1-for-20 Reverse Stock Split


Clene Quarterly report: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

Clene Quarterly report: Q1 2024


Clene Earnings release: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

Clene Earnings release: Q1 2024


Clene Proxy statement: Proxy Filing

Apr 16, 2024, 8:00 AM EDT - 2 years ago

Clene Proxy statement: Proxy Filing


Clene Proxy statement: Proxy Filing

Apr 16, 2024, 8:00 AM EDT - 2 years ago

Clene Proxy statement: Proxy Filing


Clene Proxy statement: Proxy Filing

Apr 5, 2024, 8:00 AM EDT - 2 years ago

Clene Proxy statement: Proxy Filing


Clene Annual report: Q4 2023

Mar 13, 2024, 8:00 AM EDT - 2 years ago

Clene Annual report: Q4 2023


Clene Earnings release: Q4 2023

Mar 13, 2024, 8:00 AM EDT - 2 years ago

Clene Earnings release: Q4 2023


Mulhollandr
Mulhollandr Jun. 18 at 9:23 PM
$CLNN I know we all saw it but just feel compelled to point out the 35K purchase at close. Have a nice long weekend all.
0 · Reply
Mulhollandr
Mulhollandr Jun. 18 at 3:50 PM
$CLNN less than 2 weeks till Q3 starts. 7 trading days, then the NDA filing can happen at any moment.
1 · Reply
Mulhollandr
Mulhollandr Jun. 17 at 5:40 PM
$CLNN 😃🍀🍀
2 · Reply
paule815
paule815 Jun. 17 at 10:37 AM
$CLNN 4.10?!?!?!?!? That’s just disrespectful.
2 · Reply
Mulhollandr
Mulhollandr Jun. 16 at 9:05 PM
$CLNN so I’m just now seeing the 100k in volume in the last 2 minutes of trading. WTF was that?
2 · Reply
Takeover24
Takeover24 Jun. 16 at 8:50 PM
$CLNN I added a few thousand shares at $5.52 today. First add in a while but don't expect any major movement until the fall when the NDA is accepted (may see a small bump on filing as well). But if you continue to believe in the story (which I do), this quiet period may be the last time to add significant shares at this level. Good luck to all of us.
1 · Reply
paule815
paule815 Jun. 16 at 5:35 PM
$CLNN so what’s the excuse or reasoning for the performance today?
1 · Reply
paule815
paule815 Jun. 16 at 3:41 PM
$CLNN red today
1 · Reply
Mulhollandr
Mulhollandr Jun. 15 at 11:49 PM
$CLNN Brian’s strength to fight for ALS patients is inspiring.
1 · Reply
vijaykamat14
vijaykamat14 Jun. 15 at 8:59 PM
$CLNN manifesting $20
1 · Reply
paule815
paule815 Jun. 15 at 5:44 PM
$CLNN I want to see $20
1 · Reply
vijaykamat14
vijaykamat14 Jun. 15 at 3:26 AM
$CLNN bullish week
0 · Reply
paule815
paule815 Jun. 15 at 1:51 AM
$CLNN this week?
1 · Reply
Mulhollandr
Mulhollandr Jun. 13 at 3:05 PM
$CLNN have you found any answers over the past year?
1 · Reply
justiceforb_85
justiceforb_85 Jun. 13 at 12:50 AM
$CLNN has the company released data of NfL measurements in patients treated with CNM-Au8? Concern was the lower, but not higher dose, had a mortality benefit (which questions drug efficacy). Is the same pattern seen with biomarkers?
3 · Reply
vijaykamat14
vijaykamat14 Jun. 12 at 11:27 PM
0 · Reply
Mulhollandr
Mulhollandr Jun. 12 at 4:56 PM
$CLNN selling pressure gone?🤔
1 · Reply
Mulhollandr
Mulhollandr Jun. 11 at 1:29 PM
$CLNN https://www.dovepress.com/nanomedicine-in-2026-illustrative-quantitative-analyses-of-epr-heterog-peer-reviewed-fulltext-article-IJN
2 · Reply
pyracon
pyracon Jun. 10 at 8:03 PM
$CLNN So a 1.3 million share short position now exists on a company with a 10 million share float, who has zero debt, multiple quarters of cash, who has been green lit, by the FDA, to submit for fast track designation, allowing for an NDA submittal in a matter of months, for a drug worth billions on "one" of mutual possible indications, oh yeah, and who currently trades less than 100 thousand shares per session. How could you possibly cover a 1.3 million share short position before losing several hundred percent on that bet? The only possible way is some bad news no one can legally know at this point, or an illegal arrangement with the company to cover said short position in a structured finance arrangement. Both of those options are not only highly illegal, but both would implicate management, destroying credibility forever. Wasn't paying much attention to this but now watching with great interest nownowanticipationow
1 · Reply
neuroinvestor3
neuroinvestor3 Jun. 10 at 2:16 PM
0 · Reply
vijaykamat14
vijaykamat14 Jun. 10 at 1:11 PM
0 · Reply
Chris150
Chris150 Jun. 10 at 12:54 PM
$CLNN RESCUE-ALS participant Michael O’Hehir spoke about a week ago about his condition, 6+ years from the study with CNM-Au8 in Australia. Linkedin post from Matthew Kiernan, Board Member of Clene. https://www.linkedin.com/posts/matthew-kiernan-am-100064109_junes-neura-all-staff-meeting-shone-a-topical-activity-7467836601360883712-YUZL?utm_source=share&utm_medium=member_desktop&rcm=ACoAADh0nVgB473QsirIj4H7FXjtC6g57T8PXSI
1 · Reply